Yvonne has more than 20 years of international experience and held several leadership positions and board seats in the life science, healthcare, and finance sector. Among others, she was Head of Issuer & Investor Relations of the Swiss Stock Exchange, Head of Business Development of the Hirslanden Group, CFO of EffRx Pharmaceuticals, she presided the industry promotion initiatives „Swiss Biotech“ and „Swiss Medtech“, and was a member of the non-executive Board of Directors of NovImmune and zmed. Yvonne is a trained surgeon with a doctorate in Medicine from the Zurich University. She further holds an executive MBA from the University of St. Gallen (HSG) and a Master of Corporate Finance from the University of Lucerne. She is fluent in German, English, Italian and French.